Literature DB >> 15541352

Quantum dot-antibody and aptamer conjugates shift fluorescence upon binding bacteria.

Sulatha Dwarakanath1, John G Bruno, Anant Shastry, Taylor Phillips, Ashley A John, Ashely John, Ashok Kumar, Larry D Stephenson.   

Abstract

CdSe/ZnS quantum dots (QDs) exhibited fluorescence emission blue shifts when conjugated to antibodies or DNA aptamers that are bound to bacteria. The intensity of the shifted emission peak increased with the number of bound bacteria. Curiously, the emission was consistently shifted to approximately 440-460 nm, which is distinctly different from the major component of the natural fluorescence spectrum of these QDs. This minor emission peak can grow upon conjugation to antibodies or aptamers and subsequent binding to bacterial cell surfaces. We hypothesize that the wavelength shift is due to changes in the chemical environment of the QD conjugates when they encounter the bacterial surface and may be due to physical deformation of the QD that changes the quantum confinement state. Regardless of the mechanism, these remarkable emission wavelength shifts of greater than 140 nm in some cases strongly suggest new applications for QD-receptor conjugates.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15541352     DOI: 10.1016/j.bbrc.2004.10.099

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  24 in total

1.  Modification of microneedles using inkjet printing.

Authors:  R D Boehm; P R Miller; S L Hayes; N A Monteiro-Riviere; R J Narayan
Journal:  AIP Adv       Date:  2011-06-10       Impact factor: 1.548

2.  Single-stranded DNA oligoaptamers: molecular recognition and LPS antagonism are length- and secondary structure-dependent.

Authors:  J L Ding; S T Gan; B Ho
Journal:  J Innate Immun       Date:  2008-07-12       Impact factor: 7.349

Review 3.  Functional nucleic acid sensors.

Authors:  Juewen Liu; Zehui Cao; Yi Lu
Journal:  Chem Rev       Date:  2009-05       Impact factor: 60.622

4.  Study on the intracellular fate of Tat peptide-conjugated quantum dots by spectroscopic investigation.

Authors:  Rongling Xiong; Zheng Li; Lan Mi; Pei-Nan Wang; Ji-Yao Chen; Lixin Wang; Wu-Li Yang
Journal:  J Fluoresc       Date:  2010-03       Impact factor: 2.217

5.  In vitro antibacterial effects of antilipopolysaccharide DNA aptamer-C1qrs complexes.

Authors:  J G Bruno; M P Carrillo; T Phillips
Journal:  Folia Microbiol (Praha)       Date:  2008-08-31       Impact factor: 2.099

6.  Bioimaging of nucleolin aptamer-containing 5-(N-benzylcarboxyamide)-2'-deoxyuridine more capable of specific binding to targets in cancer cells.

Authors:  Kyue Yim Lee; Hyungu Kang; Sung Ho Ryu; Dong Soo Lee; Jung Hwan Lee; Soonhag Kim
Journal:  J Biomed Biotechnol       Date:  2010-03-01

Review 7.  Revisiting the cytotoxicity of quantum dots: an in-depth overview.

Authors:  Sohrab Nikazar; Vishnu Sankar Sivasankarapillai; Abbas Rahdar; Salim Gasmi; P S Anumol; Muhammad Salman Shanavas
Journal:  Biophys Rev       Date:  2020-03-05

8.  Multiphoton microscopy of transdermal quantum dot delivery using two photon polymerization-fabricated polymer microneedles.

Authors:  Shaun D Gittard; Philip R Miller; Ryan D Boehm; Aleksandr Ovsianikov; Boris N Chichkov; Jeremy Heiser; John Gordon; Nancy A Monteiro-Riviere; Roger J Narayan
Journal:  Faraday Discuss       Date:  2011       Impact factor: 4.008

Review 9.  Quantum dots and nanoparticles for photodynamic and radiation therapies of cancer.

Authors:  Petras Juzenas; Wei Chen; Ya-Ping Sun; Manuel Alvaro Neto Coelho; Roman Generalov; Natalia Generalova; Ingeborg Lie Christensen
Journal:  Adv Drug Deliv Rev       Date:  2008-09-20       Impact factor: 15.470

10.  Single molecule resolution of the antimicrobial action of quantum dot-labeled sushi peptide on live bacteria.

Authors:  Sebastian Leptihn; Jia Yi Har; Jianzhu Chen; Bow Ho; Thorsten Wohland; Jeak Ling Ding
Journal:  BMC Biol       Date:  2009-05-11       Impact factor: 7.431

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.